Exelixis Announces Initiation of CONTACT-02 Phase 3 Pivotal Trial of Cabozantinib in Combination Wi | EXEL Message Board Posts


EXEL   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  24906 of 27781  at  6/30/2020 8:22:20 PM  by

JoeFlow


 In response to msg 24902 by  duckduffer
view thread

Re: Exelixis Announces Initiation of CONTACT-02 Phase 3 Pivotal Trial of Cabozantinib in Combination With Atezolizumab in Previously Treated Metastatic Castration-Resistant Prostate Cancer

 "This announcement pretty much derisks any concern the data may not have held up with more patients and more time."
 
agree - especially since most of the patients in Cosmic 021 were heavily pre-treated 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 7  
   Views: 325 []
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...